revised focus on inflammation

96
Focus on Inflammation (Relates to Chapter 13, “Inflammation and Wound Healing,” in the textbook) Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Upload: kellydudley

Post on 07-May-2015

177 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Revised focus on inflammation

Focus on Inflammation

(Relates to Chapter 13, “Inflammation and Wound

Healing,” in the textbook)

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 2: Revised focus on inflammation

2

Inflammatory Response

• Sequential response to cell injury– Neutralizes and dilutes inflammatory agent– Removes necrotic materials– Establishes an environment suitable for

healing and repair

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 3: Revised focus on inflammation

3

Inflammatory Response

• Mechanism of inflammation basically the same regardless of injuring agent

• Intensity of the response depends on– Extent and severity of injury– Reactive capacity of injured person

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 4: Revised focus on inflammation

4

Inflammatory Response

• Inflammatory response can be divided into: – Vascular response– Cellular response– Formation of exudate– Healing

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 5: Revised focus on inflammation

5

Page 6: Revised focus on inflammation

6

Inflammatory Response Vascular Response

• After cell injury, arterioles in area briefly undergo transient vasoconstriction.

• After release of histamine and other chemicals by the injured cells, vessels dilate, resulting in hyperemia.

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 7: Revised focus on inflammation

7

Inflammatory Response Vascular & Chemical Response

• Vasodilation chemical mediators – Endothelial cell retraction – Increased capillary permeability– Movement of fluid from capillaries into tissue

spaces

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 8: Revised focus on inflammation

8

Inflammatory Response Vascular Response

• Fluid in tissue spaces– Initially composed of serous fluid– Later contains plasma proteins, primarily

albumin• Proteins exert oncotic pressure that further draws

fluid from blood vessels.• Tissue becomes edematous.

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 9: Revised focus on inflammation

9

Inflammatory Response Vascular Response

• As plasma protein fibrinogen leaves blood, it is activated to fibrin by products of the injured cells.

• Fibrin strengthens a blood clot formed by platelets.

• In tissue, clots trap bacteria to prevent spread.

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 10: Revised focus on inflammation

10

Inflammatory Response Cellular Response

• Blood flow through capillaries in the area of inflammation slows as fluid is lost and viscosity increases.

• Neutrophils and monocytes move to the inner surface of the capillaries and then migrate through the capillary wall to the site of the injury.

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 11: Revised focus on inflammation

11

Inflammatory Response Cellular Response

• Chemotaxis– Directional migration of WBCs along

concentration gradient of chemotactic factors– Mechanism for accumulating neutrophils and

monocytes at site of injury

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 12: Revised focus on inflammation

12

Inflammatory Response Cellular Response

• Neutrophils– First leukocytes to arrive at site of injury (6 to

12 hours) – Phagocytize bacteria, other foreign material,

and damaged cells – Short life span (24 to 48 hours)

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 13: Revised focus on inflammation

13

Inflammatory Response Cellular Response

• Neutrophils– Pus is composed of

• Dead neutrophils accumulated at the site of injury• Digested bacteria• Other cell debris

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 14: Revised focus on inflammation

14

Inflammatory Response Cellular Response

• Neutrophils– Bone marrow releases more neutrophils in

response to infection, resulting in elevated WBC.

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 15: Revised focus on inflammation

15

Inflammatory Response Cellular Response

• Monocytes– Second type of phagocytic cells to migrate

to site of injury from circulating blood– Attracted to the site by chemotactic factors– Arrive within 3 to 7 days after the onset of

inflammation

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 16: Revised focus on inflammation

16

Inflammatory Response Cellular Response

• Monocytes– On entering tissue spaces, monocytes

transform into macrophages.– Assist in phagocytosis of inflammatory

debris– Macrophages have a long life span and can

multiply.

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 17: Revised focus on inflammation

17

Inflammatory Response Cellular Response

• Macrophage– Important in cleaning the area before

healing can occur– May stay in damaged tissues for weeks– Cells may fuse to form a multinucleated

giant cell.

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 18: Revised focus on inflammation

18

Inflammatory Response Cellular Response

• Lymphocytes – Arrive later at the site of injury– Primary roles of lymphocytes involve

• Cell-mediated immunity• Humoral immunity

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 19: Revised focus on inflammation

19

Inflammatory Response Cellular Response

• Exudate– Consists of fluid and leukocytes that move

from the circulation to the site of injury– Nature and quantity depend on the type and

severity of the injury and the tissues involved.

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 20: Revised focus on inflammation

20

Inflammatory Response Clinical Manifestations

• Local response to inflammation– Redness– Heat– Pain– Swelling– Loss of function

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 21: Revised focus on inflammation

21

Inflammatory Response Clinical Manifestations

• Systemic response to inflammation– Increased WBC count with a shift to the

left– Malaise– Nausea and anorexia– Increased pulse and respiratory rate– Fever

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 22: Revised focus on inflammation

22

Inflammatory Response Clinical Manifestations

• Systemic response to inflammation– The causes of the systemic response are

poorly understood, but it is probably due to complement activation and the release of cytokines.

– Some of the cytokines are IL-1, IL-6, and tumor necrosis factor.

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 23: Revised focus on inflammation

23

Inflammatory Response Clinical Manifestations

• Systemic response to inflammation – Fever

• Onset is triggered by release of cytokines.• Cytokines cause fever by initiating metabolic

changes in the temperature-regulating center.• Epinephrine released from the adrenal medulla

increases metabolic rate.

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 24: Revised focus on inflammation

24

Fig. 13-3. Production of fever. When monocytes-macrophages are activated, they secrete cytokines such as interleukin-1 (IL-1), interleukin-6 (IL-6), and tumor necrosis factor (TNF), which reach the hypothalamic temperature-regulating center. These cytokines promote the synthesis and secretion of prostaglandin E2 (PGE2) in the anterior hypothalamus.

PGE2 increases the thermostatic set point, and the

autonomic nervous system is stimulated, resulting in shivering, muscle contraction, and peripheral vasoconstriction.

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 25: Revised focus on inflammation

25Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 26: Revised focus on inflammation

26

Inflammatory Response Clinical Manifestations

• Systemic response to inflammation – Fever

• Patient then experiences chills and shivering.• Body is hot, yet person seeks warmth until the

circulating temperature reaches core body temperature.

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 27: Revised focus on inflammation

27

Inflammatory Response Clinical Manifestations

• Systemic response to inflammation – Fever

• Beneficial aspects of fever include increased killing of microorganisms, increased phagocytosis, and increased proliferation of T lymphocytes.

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 28: Revised focus on inflammation

28

Inflammatory Response Types of Inflammation

• Acute– Healing occurs in 2 to 3 weeks, usually

leaving no residual damage.– Neutrophils are the predominant cell type

at the site of inflammation.

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 29: Revised focus on inflammation

29

Inflammatory Response Types of Inflammation

• Subacute– Has same features as acute inflammation

but persists longer

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 30: Revised focus on inflammation

30

Inflammatory Response Types of Inflammation

• Chronic– May last for years– Injurious agent persists or repeats injury to

site.– Predominant cell types involved are

lymphocytes and macrophages.– May result from changes in immune

system (e.g., autoimmune disease)

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 31: Revised focus on inflammation

31

Wound Healing

• The final phase of the inflammatory response– Healing

• Two major components--regeneration and repair.

• Regeneration– Replacement of lost cells and tissues with cells

of the same type– Ability to regenerate depends on cell type.– Constantly dividing cells that rapidly regenerate

• Skin, bone marrow, lymphoid organs, as well as mucous membrane cells of the urinary, reproductive, and GI tracts

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 32: Revised focus on inflammation

32

Wound Healing• Regeneration

– Replacement of lost cells and tissues with cells of the same type

• Stable cells such as liver, bone, kidney, and pancreas regenerate in response to injury.

• Permanent cells such as neurons and skeletal and cardiac muscle do not divide.

– Neurons are replaced by glial cells or stem cells.

– Skeletal and cardiac muscle will be repaired with scar tissue.

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 33: Revised focus on inflammation

33

Wound Healing

• Repair– Healing as a result of lost cells being

replaced with connective tissue– More common than regeneration– More complex than regeneration– Occurs by primary, secondary, or tertiary

intention

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 34: Revised focus on inflammation

34Fig. 13-4. Types of wound healing. A, Primary intention. B, Secondary intention. C, Tertiary intention.

Page 35: Revised focus on inflammation

35

Wound Healing

• Repair – Primary intention

• Includes three phases– Initial phase– Granulation phase– Maturation phase and scar contraction

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 36: Revised focus on inflammation

36

Wound Healing

• Repair– Initial phase

• Lasts 3 to 5 days• Edges of incision are aligned.• Blood fills the incision area, which forms

matrix for WBC formation.• Acute inflammatory reaction occurs.

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 37: Revised focus on inflammation

37

Wound Healing

• Repair– Granulation phase

• Lasts 5 days to 3 weeks• Fibroblasts migrate to site.• Wound is pink and vascular.• Surface epithelium begins to regenerate.

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 38: Revised focus on inflammation

38

Before and After Granulating

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Fig. 13-5. A, Wound clean but not granulating (note lack of red cobblestone appearance), suggesting heavy bacterial contamination or other impediments to wound healing. B, Same wound granulating after 1 week of topical antibiotic use (note healthy red cobblestone appearance).

Page 39: Revised focus on inflammation

39

Wound Healing

• Repair Maturation phase and scar contraction

• Begins 7 days after injury and continues for several months/years

• Fibroblasts disappear as wound becomes stronger.

• Mature scar forms.

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 40: Revised focus on inflammation

40

Wound Healing

• Repair Secondary intention

• Wounds that occur from trauma, ulceration, and infection have large amounts of exudate and wide, irregular wound margins with extensive tissue loss.

• Edges cannot be approximated.• Results in more debris, cells, and exudate

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 41: Revised focus on inflammation

41

Wound Healing

• Repair Tertiary intention

• Delayed primary intention due to delayed suturing of the wound

• Occurs when a contaminated wound is left open and sutured closed after the infection is controlled

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 42: Revised focus on inflammation

42

Wound Classification

• Classified by Cause

• Surgical or nonsurgical• Acute or chronic

Depth of tissue affected• Superficial, partial thickness, full thickness

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 43: Revised focus on inflammation

43

Wound Classification

• Classified by– Color

• Red• Yellow• Black• May have two or more colors

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 44: Revised focus on inflammation

44

Delay of Healing

• Nutritional deficiencies• Inadequate blood supply• Corticosteroid drugs• Infection • Smoking

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 45: Revised focus on inflammation

45

Delay of Healing

• Mechanical friction on wound• Advanced age• Obesity • Diabetes mellitus• Poor general health • Anemia

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 46: Revised focus on inflammation

46

Complications of Healing

• Adhesions• Contractures• Dehiscence• Evisceration• Excess granulation tissue• Fistula formation

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 47: Revised focus on inflammation

47

Complications of Healing

• Infection• Hemorrhage• Hypertrophic scars• Keloid formation

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 48: Revised focus on inflammation

48

Nursing Assessment

• Assess on admission and on a regular basis.

• Identify factors that may delay healing.

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 49: Revised focus on inflammation

49

Fig. 13-9. Wound measurements are made in centimeters.

The first measurement is oriented from head to toe, the

second is from side to side, and the third is the depth (if

any). If there is any tunneling (when cotton-tipped

applicator is placed in wound,

there is movement) or undermining (when cotton-tipped

applicator is placed in wound, there is a “lip” around the

wound) this is charted in respect to a clock with 12

o’clock being toward the patient’s head. This wound

would be charted as a full-thickness, red wound, 7 cm × 5

cm × 3-cm, with a 3-cm tunnel at 7 o’clock and 2 cm

undermining from 3 o’clock to 5 o’clock.

Page 50: Revised focus on inflammation

50

Page 51: Revised focus on inflammation

51

Nursing Diagnoses

• Impaired skin integrity• Impaired tissue integrity• Risk for infection

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 52: Revised focus on inflammation

52

Nursing Implementation

• Care varies depending on– Causative agent– Degree of injury– Patient’s condition

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 53: Revised focus on inflammation

53

Nursing Implementation

• Purposes of wound management– Cleaning a wound– Treating infection– Protecting clean wound from trauma

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 54: Revised focus on inflammation

54

Nursing Implementation

• Sutures/fibrin sealant help closure.• Primary intention wounds may be

covered with dry dressing.• Drains may be inserted.• Topical antimicrobials/antibacterials

should be used with caution.

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 55: Revised focus on inflammation

55

Nursing Implementation

• Secondary intention wound care depends on etiology and type of tissue in the wound.

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 56: Revised focus on inflammation

56

Nursing Implementation

• Red Wounds Protect the wound Gentle cleaning, if needed

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 57: Revised focus on inflammation

57

Nursing Implementation

• Yellow wounds– Dressing that absorbs exudate and

cleanses the wound surface– Hydrocolloid dressings

• Black Wounds– Debridement of nonviable, eschar tissue

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 58: Revised focus on inflammation

58

Nursing Implementation

• Negative-pressure wound therapy– Suction removes drainage and speeds

healing.– Monitor serum protein levels, F&E

balance, and coagulation studies.

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 59: Revised focus on inflammation

59

Nursing Implementation

• Hyperbaric O2 – Delivery of O2 at increased atmospheric

pressure– Allows O2 to diffuse into serum– Last 90 to 120 minutes, with 10 to 60

treatments

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 60: Revised focus on inflammation

60

Nursing Implementation

• Drug therapy Becaplermin (Regranex)

• Nutritional therapy Diet high in protein, carbohydrates, and

vitamins with moderate fat

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 61: Revised focus on inflammation

61

Nursing Implementation

• Infection prevention Do not touch recently injured area. Keep environment free from possibly

contaminated items. Antibiotics may be given

prophylactically.

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 62: Revised focus on inflammation

62

Nursing Implementation

• Infection control Should cultures be done? Are they reliable? When would wound cultures be reliable? When would they be unreliable?

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 63: Revised focus on inflammation

63

Nursing Implementation

• Psychologic implications– Fear of scar or disfigurement– Drainage or odor concerns– Be aware of your facial expressions

while changing dressing.

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 64: Revised focus on inflammation

64

Patient Teaching

• Teach signs and symptoms of infection.

• Note changes in wound color or amount of drainage.

• Provide medication teaching.

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 65: Revised focus on inflammation

Focus on Pressure Ulcers

(Relates to Chapter 13, “Inflammation and Wound

Healing,” in the textbook)

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 66: Revised focus on inflammation

66

Pressure Ulcer

• A localized injury to the skin and/or underlying tissue due to pressure with or without shear/friction

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 67: Revised focus on inflammation

67

Incidence

• Most common sites Sacrum Heels

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 68: Revised focus on inflammation

68

Influencing Factors

• Amount of pressure (intensity)• Length of time pressure is exerted

(duration)• Ability of tissue to tolerate externally

applied pressure

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 69: Revised focus on inflammation

69

Contributing Factors

• Shearing force—Pressure exerted on the skin when it adheres to the bed and the skin layers slide in the direction of body movement

• Friction—Two surfaces rubbing against each other

• Excessive moisture

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 70: Revised focus on inflammation

70

Risk Factors

• Advanced age• Anemia• Contractures• Diabetes mellitus• Elevated body temperature

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 71: Revised focus on inflammation

71

Risk Factors

• Immobility• Impaired circulation• Incontinence • Low diastolic blood pressure

(<60 mm Hg)• Mental deterioration

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 72: Revised focus on inflammation

72

Risk Factors

• Neurologic disorders• Obesity • Pain• Prolonged surgery• Vascular disease

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 73: Revised focus on inflammation

73

Clinical Manifestations

• Ulcers are graded or staged according to deepest level of tissue damage:– Stage I (minor) to stage IV (severe)– Slough or eschar may have to be

removed for accurate staging of some ulcers.

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 74: Revised focus on inflammation

74

Clinical Manifestations Stage I

• Intact skin with non-blanchable redness

• Possible indicators—Skin temperature, tissue consistency, pain

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 75: Revised focus on inflammation

75

Clinical Manifestations Stage I

• May appear with red, blue, or purple hues in darker skin tones

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 76: Revised focus on inflammation

76

Clinical Manifestations Stage II

• Partial-thickness loss of dermis • Shallow open ulcer with red pink

wound bed• Presents as an intact or ruptured

serum-filled blister

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 77: Revised focus on inflammation

77

Clinical Manifestations Stage III

• Full-thickness skin loss involving damage or necrosis of subcutaneous tissue that may extend down to, but not through, underlying fascia

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 78: Revised focus on inflammation

78

Clinical Manifestations Stage III

• Presents as a deep crater with possible undermining of adjacent tissue

• Depth of ulcer varies by anatomic location.

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 79: Revised focus on inflammation

79

Clinical Manifestations Stage IV

• Full-thickness loss can extend to muscle, bone, or supporting structures.– Bone, tendon, or muscle may be visible

or palpable.

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 80: Revised focus on inflammation

80

Clinical Manifestations Stage IV

• Undermining and tunneling may also occur.

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 81: Revised focus on inflammation

81

Clinical Manifestations Infection

• Signs– Leukocytosis– Fever– Increased ulcer size, odor, or drainage– Necrotic tissue– Pain

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 82: Revised focus on inflammation

82

Clinical Manifestations Complications

• Most common—Recurrence• Cellulitis• Chronic infection• Osteomyelitis

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 83: Revised focus on inflammation

83

Assessment

• Assess pressure ulcer risk on admission and at periodic intervals based on care setting and patient’s condition.

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 84: Revised focus on inflammation

84

Assessment Tools

• Use risk assessment tools such as the Braden scale for systematic skin inspection.

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 85: Revised focus on inflammation

85

Assessment of Patients With Dark Skin

• Look for areas of skin darker (purplish, brownish, bluish) than surrounding skin.

• Use natural or halogen light for accurate assessment (fluorescent light casts a blue color that can skew results).

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 86: Revised focus on inflammation

86

Assessment of Patients With Dark Skin

• Assess skin temperature using your hand. An ulceration may feel warm initially,

then become cooler.

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 87: Revised focus on inflammation

87

Assessment of Patients With Dark Skin

• Touch the skin to feel its consistency. Boggy or edematous tissue may indicate

a stage I pressure ulcer.• Ask about pain or an itchy sensation.

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 88: Revised focus on inflammation

88

Planning

• Overall goals No deterioration Reduce contributing factors Not develop an infection Have healing Have no recurrence

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 89: Revised focus on inflammation

89

Prevention – Education

• Prevention is the best treatment.• Identify risk factors and implement

prevention strategies.

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 90: Revised focus on inflammation

90

Prevention

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 91: Revised focus on inflammation

91

Prevention – Skin Care

• Remove excessive moisture.• Avoid massage over bony

prominences.• Turn every 1 or 2 hours (with care to

avoid shearing).• Use lift sheets.

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 92: Revised focus on inflammation

92

Prevention – Skin Care

• Position with pillows or elbow and heel protectors.

• Use specialty beds.• Cleanse skin if incontinence occurs.

Use pads or briefs that are absorbent.

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 93: Revised focus on inflammation

93

Prevention – Nutrition

• Caloric intake elevated to 30 to 35 cal/kg/day or 1.25 to 1.50 g protein/kg/day– Supplements, enteral, or parenteral

feedings may be necessary.

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 94: Revised focus on inflammation

94

Treatment – Ulcer Care

• Document and describe size, stage, location, exudate, infection, pain, and tissue appearance.

• Keep ulcer bed moist.• Cleanse with nontoxic solutions.• Debride.

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 95: Revised focus on inflammation

95

Treatment – Ulcer Care

• Use adhesive membrane, ointment, or wound dressing.

• Verify good nutrition.• Teach self-care and signs of

breakdown.• Initiate specialty services.

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 96: Revised focus on inflammation

96

Operative Repair

• Skin grafts• Skin flaps• Musculocutaneous flaps• Free flaps

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.